Israel Biotech Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
20
- Portfolio
-
13
- Exits
-
2
Israel Biotech Fund General Information
Description
Israel Biotech Fund is a venture capital firm based in Rehovot, Israel. The firm seeks to make minority seed, early-stage, and later-stage investments. The firm prefers to invest in Israeli companies operating in the pharmaceutical and biotechnology sectors.
Contact Information
Website
ibf.fund
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Haogen B, 4 Oppenheimer Street
- Rehovot 7670104
- Israel
+972 000-000-0000
Israel Biotech Fund Investments (20)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 4C Biomed | 01-Jan-2023 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| 0000000 | 01-Nov-2021 | 00000 00000 | 0000 | Drug Delivery | Generating Revenue | 000 00000 |
| 00000 000000000000 | 01-Jul-2021 | 0000 00000 | Drug Discovery | Startup | ||
| 000000000 | 13-May-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000 00000 |
| 00000000 | 02-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 000000000 00.0 |
| 000000000 | 01-Feb-2020 | 0000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000000 0000 00 |
| 00000 000000000000 | 28-May-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 00000 000000000 00.0 |
| 00000 000000000 | 08-Jan-2019 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 00000 000000000 00.0 |
| TPCera | 01-Jul-2018 | Early Stage VC | 000 | Drug Discovery | Startup | |
| Ayala Pharmaceuticals | 10-Apr-2018 | Early Stage VC | 0000 | Biotechnology | Generating Revenue/Not Profitable | 00000 000000000 00.0 |
Israel Biotech Fund Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ayala Pharmaceuticals | 08-May-2020 | IPO | 000.00 |
| 000000 0000 | 26-Oct-2018 | 000 | 0000 |
Israel Biotech Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Israel Biotech Fund Team (46)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Sarit Steinberg | Chief Operating Officer & General Counsel | 0 | 0 | Rehovot, Israel | |
| Yuval Cabilly Ph.D | Co-Founder & Managing Partner | 0 | 0 | 0 | Rehovot, Israel |
| Avi Shachar | Controller | Rehovot, Israel | |||
| Keren Snir | Advisor | Rehovot, Israel | |||
| Benjamin Maisano | Venture Advisor | Rehovot, Israel |
Israel Biotech Fund Co-Investors (22)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| SBI JI Innovation Fund | 3 | 0 |
|
|
|
| Harel Insurance Investments & Financial Services | 0 | 0 |
|
|
|
| BioTelemetry | 0 | 0 |
|
|
|
| Celgene | 0 | 0 |
|
|
|
| OrbiMed | 0 | 0 |
|
|